IntelliSyn Pharma is a med chem, synthesis, and biology-focused group that spun out following the closure of AstraZeneca’s Montreal Research site.  90% of our staff have Ph.Ds, most with 10-15 years’ experience.  We work with clients to provide innovative problem solving and efficient read moreproject advancement. 

Since beginning in 2012, our scientists have been named as co-inventors on 16 patent applications and have identified 3 clinical candidates for our clients.  We provide support and innovation on a flexible basis.  Our location in Canada allows generous tax credits; thus, we can work on a very cost effective basis compared with other North American or European groups. [website]